RJA
TPTX

Raymond James & Associates’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Raymond James & Associates’s Portfolio TPTX Stock Details TPTX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
2022
Q1 		$281K Buy
2021
Q4 		$423K Sell
2021
Q3 		$664K Sell
2021
Q2 		$808K Sell
2021
Q1 		$989K Sell
2020
Q4 		$1.29M Sell
2020
Q3 		$967K Sell
2020
Q2 		$732K Buy